The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
Open accessAbstract
Dendritic cells (DC) are essential in immunity due to their role in activating T cells thereby promoting anti-tumorigenic responses. Tumor cells, however, hijack the immune system causing T cell exhaustion and DC dysfunction. Tumor-induced T cell exhaustion may be reversed through immune checkpoint blockade (ICB), however, this treatment fails to show clinical benefit in many patients. While ICB serves to reverse T cell exhaustion, DCs are still necessary to prime, activate and direct the T cells to target tumor cells. In this review we will provide a brief overview of DC function, describe mechanisms by which DC functions are disrupted by the tumor microenvironment and highlight recent developments in DC cancer vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
An immunogenic personal neoantigen vaccine for patients with melanoma
Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., et al. (2017) · Nature · doi:10.1038/nature22991 · Cited by 2,936
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Van Allen, E. M., Miao, D., Schilling, B., Shukla, S. A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Geukes Foppen, M. H., Goldinger, S. M., et al. (2015) · Science · doi:10.1126/science.aad0095 · Cited by 2,839
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Sahin, U., Derhovanessian, E., Miller, M., Kloke, B.-P., Simon, P., Löwer, M., Bukur, V., Tadmor, A. D., Luxemburger, U., Schrörs, B., et al. (2017) · Nature · doi:10.1038/nature23003 · Cited by 2,488
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Villani, A.-C., Satija, R., Reynolds, G., Sarkizova, S., Shekhar, K., Fletcher, J., Griesbeck, M., Butler, A., Zheng, S., Lazo, S., et al. (2017) · Science · doi:10.1126/science.aah4573 · Cited by 2,413 · cited 1×
“However, the exact physiological role of these subgroups in vivo remains to be determined [2].”
BackgroundBatf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B. U., Unanue, E. R., Diamond, M. S., et al. (2008) · Science · doi:10.1126/science.1164206 · Cited by 2,081
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., et al. (2014) · Nature · doi:10.1038/nature13988 · Cited by 1,974
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases
Mempel, T. R., Henrickson, S. E., & von Andrian, U. H. (2004) · Nature · doi:10.1038/nature02238 · Cited by 1,714
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
Hui, E., Cheung, J., Zhu, J., Su, X., Taylor, M. J., Wallweber, H. A., Sasmal, D. K., Huang, J., Kim, J. M., Mellman, I., et al. (2017) · Science · doi:10.1126/science.aaf1292 · Cited by 1,689
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade
Wei, S. C., Levine, J. H., Cogdill, A. P., Zhao, Y., Anang, N.-A. A. S., Andrews, M. C., Sharma, P., Wang, J., Wargo, J. A., Pe’er, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.024 · Cited by 1,302
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Carreno, B. M., Magrini, V., Becker-Hapak, M., Kaabinejadian, S., Hundal, J., Petti, A. A., Ly, A., Lie, W.-R., Hildebrand, W. H., Mardis, E. R., et al. (2015) · Science · doi:10.1126/science.aaa3828 · Cited by 1,285
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Lavin, Y., Kobayashi, S., Leader, A., Amir, E.-A. D., Elefant, N., Bigenwald, C., Remark, R., Sweeney, R., Becker, C. D., Levine, J. H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.014 · Cited by 1,209
Salmon, H., Idoyaga, J., Rahman, A., Leboeuf, M., Remark, R., Jordan, S., Casanova-Acebes, M., Khudoynazarova, M., Agudo, J., Tung, N., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.012 · Cited by 1,201
Self-citationNapolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., & Lanzavecchia, A. (2005) · Nature Immunology · doi:10.1038/ni1223 · Cited by 1,157
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Ten years of anti-vascular endothelial growth factor therapy
Ferrara, N., & Adamis, A. P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.17 · Cited by 1,030
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
Kamphorst, A. O., Wieland, A., Nasti, T., Yang, S., Zhang, R., Barber, D. L., Konieczny, B. T., Daugherty, C. Z., Koenig, L., Yu, K., et al. (2017) · Science · doi:10.1126/science.aaf0683 · Cited by 1,015
Targeting neoantigens to augment antitumour immunity
Yarchoan, M., Johnson, B. A., Lutz, E. R., Laheru, D. A., & Jaffee, E. M. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.154 · Cited by 997
Indirect activation of naïve CD4+ T cells by dendritic cell–derived exosomes
Théry, C., Duban, L., Segura, E., Véron, P., Lantz, O., & Amigorena, S. (2002) · Nature Immunology · doi:10.1038/ni854 · Cited by 960
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
Cubillos-Ruiz, J. R., Silberman, P. C., Rutkowski, M. R., Chopra, S., Perales-Puchalt, A., Song, M., Zhang, S., Bettigole, S. E., Gupta, D., Holcomb, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.025 · Cited by 933 · cited 1×
“Interestingly, treatment with antioxidants and inhibition of XBP-1 expression using nano-particles successfully relieved the ER stress on DCs restoring their potential to activate T cell and resulting in tumor regression [53, 54].”
MethodTim‐3 and its role in regulating anti‐tumor immunity
Das, M., Zhu, C., & Kuchroo, V. K. (2017) · Immunological Reviews · doi:10.1111/imr.12520 · Cited by 856
Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.87 · Cited by 828
Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species
Guilliams, M., Dutertre, C.-A., Scott, C. L., McGovern, N., Sichien, D., Chakarov, S., Van Gassen, S., Chen, J., Poidinger, M., De Prijck, S., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.015 · Cited by 822
Banchereau, J., Palucka, A. K., Dhodapkar, M. V., Burkeholder, S. B., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K. M., Bhardwaj, N., et al. (2001) · PubMed · Cited by 806
Self-citationPROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Cheever, M. A., & Higano, C. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3126 · Cited by 780
Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., & Zitvogel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050463 · Cited by 776
Allan, R. S., Waithman, J., Bedoui, S., Jones, C. M., Villadangos, J. A., Zhan, Y., Lew, A. M., Shortman, K., Heath, W. R., & Carbone, F. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.017 · Cited by 757
Duraiswamy, J., Kaluza, K. M., Freeman, G. J., & Coukos, G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4100 · Cited by 745
Lipid accumulation and dendritic cell dysfunction in cancer
Herber, D. L., Cao, W., Nefedova, Y., Novitskiy, S. V., Nagaraj, S., Tyurin, V. A., Corzo, A., Cho, H.-I., Celis, E., Lennox, B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2172 · Cited by 735
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Fu, J., Kanne, D. B., Leong, M., Glickman, L. H., McWhirter, S. M., Lemmens, E., Mechette, K., Leong, J. J., Lauer, P., Liu, W., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4306 · Cited by 720
Wallin, J. J., Bendell, J. C., Funke, R., Sznol, M., Korski, K., Jones, S., Hernandez, G., Mier, J., He, X., Hodi, F. S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12624 · Cited by 713
A molecular portrait of microsatellite instability across multiple cancers
Cortes-Ciriano, I., Lee, S., Park, W.-Y., Kim, T.-M., & Park, P. J. (2017) · Nature Communications · doi:10.1038/ncomms15180 · Cited by 658
Dendritic cell-derived exosomes for cancer therapy.
Pitt, J. M., André, F., Amigorena, S., Soria, J.-C., Eggermont, A., Kroemer, G., & Zitvogel, L. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81137 · Cited by 636
Okada, H., Kalinski, P., Ueda, R., Hoji, A., Kohanbash, G., Donegan, T. E., Mintz, A. H., Engh, J. A., Bartlett, D. L., Brown, C. K., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7744 · Cited by 567
Lahn, M., Herbertz, S., Sawyer, J. S., Stauber, A. J., Gueorguieva, I., Driscoll, K. E., Estrem, S. T., Cleverly, A. L., Desaiah, D., Guba, S. C., et al. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s86621 · Cited by 554
Metalloproteinases and their natural inhibitors in inflammation and immunity
Khokha, R., Murthy, A., & Weiss, A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3499 · Cited by 552
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Mitchell, D. A., Batich, K. A., Gunn, M. D., Huang, M.-N., Sanchez-Perez, L., Nair, S. K., Congdon, K. L., Reap, E. A., Archer, G. E., Desjardins, A., et al. (2015) · Nature · doi:10.1038/nature14320 · Cited by 531
Mechanisms and Consequences of Dendritic Cell Migration
Alvarez, D., Vollmann, E. H., & von Andrian, U. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.006 · Cited by 525
Collin, M., McGovern, N., & Haniffa, M. (2013) · Immunology · doi:10.1111/imm.12117 · Cited by 500
The paradoxical role of IL-10 in immunity and cancer
Mannino, M. H., Zhu, Z., Xiao, H., Bai, Q., Wakefield, M. R., & Fang, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.009 · Cited by 473
The role of CD40 and CD154/CD40L in dendritic cells
Ma, D. Y., & Clark, E. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.010 · Cited by 446
Dendritic cells in cancer: the role revisited
Veglia, F., & Gabrilovich, D. I. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.01.002 · Cited by 443
Gerner, M. Y., Kastenmuller, W., Ifrim, I., Kabat, J., & Germain, R. N. (2012) · Immunity · doi:10.1016/j.immuni.2012.07.011 · Cited by 425
Innate immune signaling and regulation in cancer immunotherapy
Corrales, L., Matson, V., Flood, B., Spranger, S., & Gajewski, T. F. (2017) · Cell Research · doi:10.1038/cr.2016.149 · Cited by 408
Eric, L., Yeo, C. J., Lillemoe, K. D., Biedrzycki, B., Kobrin, B., Herman, J., Sugar, E., Piantadosi, S., Cameron, J. L., Solt, S., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e3181fd271c · Cited by 403
Porgador, A., & Gilboa, E. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.255 · Cited by 362
Tel, J., Aarntzen, E. H. J. G., Baba, T., Schreibelt, G., Schulte, B. M., Benitez-Ribas, D., Boerman, O. C., Croockewit, S., Oyen, W. J. G., van Rossum, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2583 · Cited by 353
Immunoregulation by members of the TGFβ superfamily
Chen, W., & ten Dijke, P. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.112 · Cited by 347
Laheru, D., Lutz, E., Burke, J., Biedrzycki, B., Solt, S., Onners, B., Tartakovsky, I., Nemunaitis, J., Le, D., Sugar, E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0371 · Cited by 346
Mackensen, A., Herbst, B., Chen, J.-L., K�hler, G., Noppen, C., Herr, W., Spagnoli, G. C., Cerundolo, V., & Lindemann, A. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-t · Cited by 345
Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy
Chang, L., Chang, M., Chang, H. M., & Chang, F. (2018) · Applied Immunohistochemistry & Molecular Morphology · doi:10.1097/pai.0000000000000575 · Cited by 345
Nair-Gupta, P., Baccarini, A., Tung, N., Seyffer, F., Florey, O., Huang, Y., Banerjee, M., Overholtzer, M., Roche, P. A., Tampé, R., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.054 · Cited by 325
Cancer immunotherapy with mRNA‐transfected dendritic cells
Gilboa, E., & Vieweg, J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00139.x · Cited by 316
Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
Young, A., Mittal, D., Stagg, J., & Smyth, M. J. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0341 · Cited by 310
Combining Epigenetic and Immunotherapy to Combat Cancer
Chiappinelli, K. B., Zahnow, C. A., Ahuja, N., & Baylin, S. B. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2125 · Cited by 309
Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection
Wakim, L. M., & Bevan, M. J. (2011) · Nature · doi:10.1038/nature09863 · Cited by 307
Inflammatory dendritic cells in mice and humans
Segura, E., & Amigorena, S. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.06.001 · Cited by 300
Gerner, M. Y., Torabi-Parizi, P., & Germain, R. N. (2015) · Immunity · doi:10.1016/j.immuni.2014.12.024 · Cited by 299
The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules
Cruz, F. M., Colbert, J. D., Merino, E., Kriegsman, B. A., & Rock, K. L. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055254 · Cited by 299
Tumor-derived exosomes modulate PD-L1 expression in monocytes
Haderk, F., Schulz, R., Iskar, M., Cid, L. L., Worst, T., Willmund, K. V., Schulz, A., Warnken, U., Seiler, J., Benner, A., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aah5509 · Cited by 298
Dendritic Cells Display Subset and Tissue-Specific Maturation Dynamics over Human Life
Granot, T., Senda, T., Carpenter, D. J., Matsuoka, N., Weiner, J., Gordon, C. L., Miron, M., Kumar, B. V., Griesemer, A., Ho, S.-H., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.019 · Cited by 290
Hor, J. L., Whitney, P. G., Zaid, A., Brooks, A. G., Heath, W. R., & Mueller, S. N. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.020 · Cited by 285
Chodon, T., Comin-Anduix, B., Chmielowski, B., Koya, R. C., Wu, Z., Auerbach, M., Ng, C., Avramis, E., Seja, E., Villanueva, A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3017 · Cited by 259
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
Scandella, E., Men, Y., Legler, D. F., Gillessen, S., Prikler, L., Ludewig, B., & Groettrup, M. (2004) · Blood · doi:10.1182/blood-2003-05-1643 · Cited by 256
Schreibelt, G., Klinkenberg, L. J. J., Cruz, L. J., Tacken, P. J., Tel, J., Kreutz, M., Adema, G. J., Brown, G. D., Figdor, C. G., & de Vries, I. J. M. (2012) · Blood · doi:10.1182/blood-2011-08-373944 · Cited by 252
Brown, G. T., & Murray, G. I. (2015) · The Journal of Pathology · doi:10.1002/path.4586 · Cited by 241
Schreibelt, G., Bol, K. F., Westdorp, H., Wimmers, F., Aarntzen, E. H. J. G., Duiveman-de Boer, T., van de Rakt, M. W. M. M., Scharenborg, N. M., de Boer, A. J., Pots, J. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2205 · Cited by 241
Dendritic cell maturation and cross‐presentation: timing matters!
Alloatti, A., Kotsias, F., Magalhaes, J. G., & Amigorena, S. (2016) · Immunological Reviews · doi:10.1111/imr.12432 · Cited by 241
Naing, A., Papadopoulos, K. P., Autio, K. A., Ott, P. A., Patel, M. R., Wong, D. J., Falchook, G. S., Pant, S., Whiteside, M., Rasco, D. R., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.1106 · Cited by 222
Chiang, C. L.-L., Kandalaft, L. E., Tanyi, J., Hagemann, A. R., Motz, G. T., Svoronos, N., Montone, K., Mantia-Smaldone, G. M., Smith, L., Nisenbaum, H. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1185 · Cited by 218
Lee, A. W., Truong, T., Bickham, K., Fonteneau, J.-F., Larsson, M., Da Silva, I., Somersan, S., Thomas, E. K., & Bhardwaj, N. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00382-1 · Cited by 207
Self-citationWilgenhof, S., Van Nuffel, A. M. T., Benteyn, D., Corthals, J., Aerts, C., Heirman, C., Van Riet, I., Bonehill, A., Thielemans, K., & Neyns, B. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt245 · Cited by 203
Alloatti, A., Kotsias, F., Pauwels, A.-M., Carpier, J.-M., Jouve, M., Timmerman, E., Pace, L., Vargas, P., Maurin, M., Gehrmann, U., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.11.006 · Cited by 189
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
Macri, C., Dumont, C., Johnston, A. P., & Mintern, J. D. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.6 · Cited by 182
Ratzinger, G., Baggers, J., de Cos, M. A., Yuan, J., Dao, T., Reagan, J. L., Münz, C., Heller, G., & Young, J. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2780 · Cited by 175
Boullart, A. C. I., Aarntzen, E. H. J. G., Verdijk, P., Jacobs, J. F. M., Schuurhuis, D. H., Benítez‐Ribas, D., Schreibelt, G., van de Rakt, M. W. M. M., Scharenborg, N. M., de Boer, A. J., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0489-2 · Cited by 172
Immune Checkpoints as a Target for Colorectal Cancer Treatment
Passardi, A., Canale, M., Valgiusti, M., & Ulivi, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061324 · Cited by 172
Tang, M., Diao, J., Gu, H., Khatri, I. A., Zhao, J., & Cattral, M. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.053 · Cited by 166
Hiltbold, E. M., Vlad, A. M., Ciborowski, P., Watkins, S. C., & Finn, O. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3730 · Cited by 165
Rosenblatt, J., Stone, R. M., Uhl, L., Neuberg, D., Joyce, R., Levine, J. D., Arnason, J., McMasters, M., Luptakova, K., Jain, S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1298 · Cited by 164
Yewdall, A. W., Drutman, S. B., Jinwala, F., Bahjat, K. S., & Bhardwaj, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011144 · Cited by 162
Self-citationCarbone, F. R., Belz, G. T., & Heath, W. R. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.013 · Cited by 160
Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer
Huber, M. L., Haynes, L., Parker, C. C., & Iversen, P. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr514 · Cited by 158
Immunoregulatory roles of versican proteolysis in the myeloma microenvironment
Hope, C. L., Foulcer, S. J., Jagodinsky, J. C., Chen, S. X., Jensen, J. L., Patel, S., Leith, C. P., Maroulakou, I. G., Callander, N. S., Miyamoto, S., et al. (2016) · Blood · doi:10.1182/blood-2016-03-705780 · Cited by 153
Henrickson, S. E., Perro, M., Loughhead, S. M., Senman, B. C., Stutte, S., Quigley, M. M., Alexe, G., Iannacone, M., Flynn, M. P., Omid, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.034 · Cited by 145
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO
Mondanelli, G., Ugel, S., Grohmann, U., & Bronte, V. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.05.002 · Cited by 138
CSF-1/CSF-1R targeting agents in clinical development for cancer therapy
Ries, C. H., Hoves, S., Cannarile, M. A., & Rüttinger, D. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.05.008 · Cited by 134
Lundberg, K., Albrekt, A.-S., Nelissen, I., Santegoets, S. J. A. M., de Gruijl, T. D., Gibbs, S., & Lindstedt, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052875 · Cited by 117
Hanlon, D. J., Saluja, S. S., Sharp, F. A., Hong, E., Khalil, D., Tigelaar, R. E., Fahmy, T. M., Edelson, R. L., & Robinson, E. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s66639 · Cited by 113
Carlos, C. A., Dong, H., Howard, O. M. Z., Oppenheim, J. J., Hanisch, F., & Finn, O. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1628 · Cited by 105
Oudard, S., Rixe, O., Beuselinck, B., Linassier, C., Banu, E., Machiels, J., Baudard, M., Ringeisen, F., Velu, T., Lefrère-Belda, M., et al. (2011) · Cancer Immunology and Immunotherapy · doi:10.1007/s00262-010-0935-9 · Cited by 101
Tumoral Immune Resistance Mediated by Enzymes That Degrade Tryptophan
van Baren, N., & den Eynde, B. J. V. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0095 · Cited by 101
Lipson, E. J., Sharfman, W. H., Chen, S., McMiller, T. L., Pritchard, T. S., Salas, J. T., Sartorius-Mergenthaler, S., Freed, I., Ravi, S., Wang, H., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0572-3 · Cited by 100
Human dendritic cell line models for DC differentiation and clinical DC vaccination studies
Santegoets, S. J. A. M., van den Eertwegh, A. J. M., van de Loosdrecht, A. A., Scheper, R. J., & de Gruijl, T. D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208092 · Cited by 97
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
Lint, S. V., Wilgenhof, S., Heirman, C., Corthals, J., Breckpot, K., Bonehill, A., Neyns, B., & Thielemans, K. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1558-3 · Cited by 96
Miwa, S., Nishida, H., Tanzawa, Y., Takeuchi, A., Hayashi, K., Yamamoto, N., Mizukoshi, E., Nakamoto, Y., Kaneko, S., & Tsuchiya, H. (2017) · Cancer · doi:10.1002/cncr.30606 · Cited by 95
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
Vandenberk, L., Belmans, J., Woensel, M. V., Riva, M., & Gool, S. V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00663 · Cited by 94
Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells.
Hiltbold, E. M., Ciborowski, P. S., & Finn, O. J. (1998) · PubMed · Cited by 90
Nicola, M. D., Carlo‐Stella, C., Mortarini, R., Baldassari, P., Guidetti, A., Gallino, G., Vecchio, M. D., Ravagnani, F., Magni, M., Chaplin, P. J., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0602 · Cited by 86
Targeting adenosine in cancer immunotherapy: a review of recent progress
Whiteside, T. L. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1316197 · Cited by 86
Neoantigen-based cancer immunotherapy
Bobisse, S., Foukas, P. G., Coukos, G., & Harari, A. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.06.17 · Cited by 85
Song, S., Yuan, P., Wu, H., Chen, J., Fu, J., Li, P., Lu, J., & Wei, W. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.027 · Cited by 84
Weber, F., Byrne, S. N., Le, S., Brown, D. A., Breit, S. N., Scolyer, R. A., & Halliday, G. M. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0652-3 · Cited by 83
Verronèse, E., Delgado, A. S., Valladeau‐Guilemond, J., Garin, G., Guillemaut, S., Trédan, O., Ray-Coquard, I., Bachelot, T., Nkodia, A., Bardin-dit-Courageot, C., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1100791 · Cited by 82
Dendritic-Tumor Fusion Cell-Based Cancer Vaccines
Koido, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060828 · Cited by 81
Poschke, I. C., Lövgren, T., Adamson, L., Nystrom, M. L., Andersson, E. K., Hansson, J., Tell, R., Masucci, G. V., & Kiessling, R. W. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1575-2 · Cited by 78
Godefroy, E., Manches, O., Dréno, B., Hochman, T., Rolnitzky, L. M., Labarrière, N., Guilloux, Y., Goldberg, J. D., Jotereau, F., & Bhardwaj, N. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.037 · Cited by 76
Self-citationDistinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells
Tanne, A., Muniz, L. R., Puzio-Kuter, A., Leonova, K. I., Gudkov, A. V., Ting, D. T., Monasson, R., Cocco, S., Levine, A. J., Bhardwaj, N., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517584112 · Cited by 74
Self-citationReview of Mouse and Human Dendritic Cell Subsets
Segura, É. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3606-9_1 · Cited by 73
Modulation of innate immunity in the tumor microenvironment
González-Gugel, E., Saxena, M., & Bhardwaj, N. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1859-9 · Cited by 69
Self-citationAkasaki, Y., Kikuchi, T., Homma, S., Koido, S., Ohkusa, T., Tasaki, T., Hayashi, K., Komita, H., Watanabe, N., Suzuki, Y., et al. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1905-7 · Cited by 67
Nuffel, A. M. T. V., Benteyn, D., Wilgenhof, S., Corthals, J., Heirman, C., Neyns, B., Thielemans, K., & Bonehill, A. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1176-2 · Cited by 66
Macrophage colony-stimulating factor and cancer: a review
Chockalingam, S., & Ghosh, S. S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2627-0 · Cited by 64
Pen, J. J., Keersmaecker, B. D., Maenhout, S. K., Nuffel, A. M. T. V., Heirman, C., Corthals, J., Escors, D., Bonehill, A., Thielemans, K., Breckpot, K., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201008 · Cited by 60
Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines
Saxena, M., & Bhardwaj, N. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.06.003 · Cited by 59
Self-citationAlarmins and Antitumor Immunity
Nie, Y., Yang, D., & Oppenheim, J. J. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.021 · Cited by 58
Sundarasetty, B. S., Chan, L., Darling, D., Giunti, G., Farzaneh, F., Schenck, F., Naundorf, S., Kuehlcke, K., Ruggiero, E., Schmidt, M., et al. (2015) · Gene Therapy · doi:10.1038/gt.2015.43 · Cited by 46
Lohmueller, J. J., Sato, S., Popova, L., Chu, I. M., Tucker, M., Barberena, R., Innocenti, G., Čudić, M., Ham, J. D., Cheung, W. C., et al. (2016) · Scientific Reports · doi:10.1038/srep31740 · Cited by 43
CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations
Nimanong, S., Ostroumov, D., Wingerath, J., Knocke, S., Woller, N., Gürlevik, E., Falk, C. S., Manns, M. P., Kühnel, F., & Wirth, T. C. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2089 · Cited by 43
Godefroy, E., Gallois, A., Idoyaga, J., Mérad, M., Tung, N., Monu, N. R., Saenger, Y. M., Fu, Y., Ravindran, R., Pulendran, B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.067 · Cited by 42
Self-citationMarti, L. C., Pavon, L. F., Severino, P., Sibov, T. T., Guilhen, D. D., & Moreira‐Filho, C. A. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276130252 · Cited by 41
Moving to the suburbs: T‐cell positioning within lymph nodes during activation and memory
Groom, J. R. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.29 · Cited by 40
Thompson, E. A., Liang, F., Lindgren, G., Sandgren, K. J., Quinn, K. M., Darrah, P. A., Koup, R. A., Seder, R. A., Kedl, R. M., & Loré, K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500078 · Cited by 39
Clancy‐Thompson, E., King, L. K., Nunnley, L. D., Mullins, I. M., Slingluff, C. L., & Mullins, D. W. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0084 · Cited by 37
In Vitro Generation of Human XCR1+ Dendritic Cells from CD34+ Hematopoietic Progenitors
Balan, S., & Dalod, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3606-9_2 · Cited by 34
Pharmacological DNA demethylation: Implications for cancer immunotherapy
Roulois, D., Yau, H. L., & Carvalho, D. D. D. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1090077 · Cited by 31
IL-10-producing CD4+ T cells negatively regulate fucosylation of epithelial cells in the gut
Goto, Y., Lamichhane, A., Kamioka, M., Sato, S., Honda, K., Kunisawa, J., & Kiyono, H. (2015) · Scientific Reports · doi:10.1038/srep15918 · Cited by 31
Zhang, L., Yang, X., Sun, Z., Li, J., ZHU, H., Li, J., & Pang, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4273 · Cited by 30
Kumar, J., Kale, V. P., & Limaye, L. S. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0160-8 · Cited by 29
Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes
Moeller, I., Spagnoli, G. C., Finke, J., Veelken, H., & Houet, L. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1272-y · Cited by 28
González, F. E., Ortiz, C., Reyes, M., Dutzan, N., Patel, V., Pereda, C., Gleisner, M. A., López, M. N., Gutkind, J. S., & Salazar‐Onfray, F. (2014) · Immunology · doi:10.1111/imm.12264 · Cited by 25
Sabado, R. L., Meseck, M. L., & Bhardwaj, N. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3387-7_44 · Cited by 24
Self-citationMosińska, P., Gabryelska, A., Zasada, M., & Fichna, J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00126 · Cited by 23
Targeting abnormal ER stress responses in tumors: A new approach to cancer immunotherapy
Cubillos‐Ruiz, J. R., & Glimcher, L. H. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1098802 · Cited by 18
Dendritic Cell Targeting Vaccine for HPV-Associated Cancer
Yin, W., Duluc, D., Joo, H., & Oh, S. (2017) · Cancer Cell & Microenvironment · doi:10.14800/ccm.1482 · Cited by 18
Benteyn, D., Nuffel, A. M. T. V., Wilgenhof, S., & Bonehill, A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0345-0_1 · Cited by 16
Next-Generation Dendritic Cell-Based Vaccines for Leukemia Patients
Hoffmann, J., Schmitt, M. W., Ni, M., & Schmitt, A. (2017) · Immunotherapy · doi:10.2217/imt-2016-0116 · Cited by 13
Chimeric Antigen Receptor Therapy in Acute Lymphoblastic Leukemia Clinical Practice
Luskin, M. R., & DeAngelo, D. J. (2017) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-017-0394-x · Cited by 13
Against the self: dendritic cells versus cancer
Cho, H. J., & Bhardwaj, N. (2003) · Apmis · doi:10.1034/j.1600-0463.2003.11107812.x · Cited by 8
Self-citation
Cited by
The Tumor Microenvironment Innately Modulates Cancer Progression
Hinshaw, D. C., & Shevde, L. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3962 · Cited by 3,270
Dendritic cells in cancer immunology and immunotherapy
Wculek, S. K., Cueto, F. J., Mujal, A. M., Melero, I., Krummel, M. F., & Sancho, D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0210-z · Cited by 2,574
Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Self-citationThe lung microenvironment: an important regulator of tumour growth and metastasis
Altorki, N. K., Markowitz, G. J., Gao, D., Port, J. L., Saxena, A., Stiles, B., McGraw, T., & Mittal, V. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0081-9 · Cited by 1,150
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Blass, E., & Ott, P. A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00460-2 · Cited by 1,042
Metadata
- Authors
- Saxena, M., & Bhardwaj, N.
- Venue
- Trends in Cancer
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 4
- Issue
- 2
- Pages
- 119-137
- ISSN
- 2405-8025 (ISSN-L)
- 2405-8033
- OpenAlex
- W2784346742
- Cited by
- 305
- References
- 145
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.